Polaris To Discuss Sunshine Act Impact on Pharma Meetings Planning At CBI Pharma Forum
Lead Partner Marc Eigner To Address Specific Compliance Risks For Internal Meeting Planning Departments As Well As Meeting Planning Products & Services Providers.
An increased focus has been put on the mounting compliance challenges facing the meetings planning function at life sciences companies resulting from the PPACA’s Sunshine Act provision. Polaris lead partner Marc Eigner will offer new perspectives on these growing compliance risks for meetings organizers, including the operational impact these risks are having on meetings planning departments, and some of the major compliance “blind spots” how they can be addressed at the CBI Pharma Forum in Orlando on March 23-26 (http://www.cbinet.com/conference/pc14086).
Eigner will present his insights as part of panel discussion that will take place on Monday, March 24th at 4:15PM EDT.
Eigner will also be on hand at the Polaris booth following the panel discussion to answer questions about additional issues facing the pharma meetings planning industry, including:
- Why there is an urgent need for compliance training and certification of meetings planning staff as well as meetings planning products and services providers
- How remote and mobile technology platforms will become increasingly critical for tracking meeting attendees
- Why compliance protocols and systems must be synchronized between meetings planning departments and external meetings planning products and services providers